SAP30L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.137800E-01
Normal-vs-Stage2
1.130850E-01
Normal-vs-Stage3
8.920300E-02
Normal-vs-Stage4
5.952600E-01
Stage1-vs-Stage2
6.800500E-02
Stage1-vs-Stage3
8.223600E-03
Stage1-vs-Stage4
6.285200E-01
Stage2-vs-Stage3
7.797400E-04
Stage2-vs-Stage4
4.237800E-01
Stage3-vs-Stage4
1.374620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.756630E-01
Normal-vs-AfricanAmerican
5.061000E-01
Normal-vs-Asian
1.004600E-01
Caucasian-vs-AfricanAmerican
4.116800E-01
Caucasian-vs-Asian
2.610400E-01
AfricanAmerican-vs-Asian
1.789400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.061400E-01
Normal-vs-Female
1.519430E-01
Male-vs-Female
8.558600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.898200E-01
Normal-vs-Age(41-60Yrs)
4.621200E-01
Normal-vs-Age(61-80Yrs)
1.109610E-01
Normal-vs-Age(81-100Yrs)
6.262000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.441800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.805400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.608200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.595580E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.394000E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.442440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.470200E-02
Normal-vs-Daily Drinker
1.275240E-01
Normal-vs-Weekly Drinker
1.337000E-01
Normal-vs-Occasional Drinker
1.272840E-01
Normal-vs-Social Drinker
8.578400E-01
Non Drinker-vs-Daily Drinker
6.508000E-01
Non Drinker-vs-Weekly Drinker
6.573800E-01
Non Drinker-vs-Occasional Drinker
2.595800E-01
Non Drinker-vs-Social Drinker
2.968000E-02
Daily Drinker-vs-Weekly Drinker
9.758000E-01
Daily Drinker-vs-Occasional Drinker
5.719800E-01
Daily Drinker-vs-Social Drinker
4.718100E-02
Weekly Drinker-vs-Occasional Drinker
6.180400E-01
Weekly Drinker-vs-Social Drinker
8.530300E-02
Occasional Drinker-vs-Social Drinker
1.276800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.443590E-01
Normal-vs-Grade 2
2.296300E-02
Normal-vs-Grade 3
1.647920E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.530000E-01
Grade 1-vs-Grade 3
7.160400E-01
Grade 1-vs-Grade 4
1.443590E-01
Grade 2-vs-Grade 3
5.813400E-01
Grade 2-vs-Grade 4
2.296300E-02
Grade 3-vs-Grade 4
1.647920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.295700E-02
Normal-vs-NonDiabetic
2.000600E-01
Diabetic-vs-NonDiabetic
2.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.738000E-01
Normal-vs-NoPancreatitis
1.501400E-01
Pancreatitis-vs-NoPancreatitis
2.876800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.339600E-01
Normal-vs-N1
1.160440E-01
N0-vs-N1
3.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.555760E-01
Normal-vs-TP53-NonMutant
5.962800E-01
TP53-Mutant-vs-TP53-NonMutant
4.021900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
